Back to remote jobs

Biotech Investment Analyst — Drug Asset & Company Assessment

Mercor

AI Expert - Finance Contractor
United States $125 – $200/hr August 5, 2026

Job description

Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a paid pilot, with the potential to continue as the work scales.

Responsibilities

  • Create and critique rubrics that analyze commercial drugs and drug-development programs

  • Provide overall company and asset assessment — mechanism, clinical data, competitive position, and value drivers

  • Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions

  • Apply your assessment across the pilot's set of companies (~5–10)

Requirements

  • US-based biotech / healthcare investment analyst with a specialist-fund background

  • Familiarity with biotech/pharma development programs

  • Able to assess a drug asset and the company behind it end-to-end

  • 5+ years evaluating biotech/pharma companies or assets

Engagement Details

  • Duration: Approximately 10–20 hours over a 1–2 week pilot

  • Remote — US-based

Why Participate

  • Help improve expert AI evaluation of drugs and drug-development programs

  • Recurring engagement for strong contributors

Who can apply

Open to
United States
Posted
August 5, 2026 by Mercor
Last checked
November 17, 2026: still open on work.mercor.com, where you apply
Apply now

Opens work.mercor.com in a new tab. If they ask how you found the role, mention RemoWork.

Open to applicants in the United States
Apply now

Stay in the loop.

Occasional emails with our new remote-work guides. No spam, unsubscribe anytime.